Modern Genomic Services

05/06/2023

【Stool DNA Colon Cancer Screening Test by Eurofins MGS】

Colorectal cancer is the 2nd commonest cancer in Hong Kong. Aging, poor diet, genetic factors and other chronic bowel diseases may lead to a higher chance of colorectal cancer.

In January this year, we have launched our Stool DNA Colon Cancer Screening Test.

This test provides a safe, simple and accurate for screening colorectal cancer. With just a small amount of stool sample, this test examines multiple genetic alternations associated with colorectal cancer.

✅ CAP-accredited laboratory
✅ Highly Sensitive (95.3% sensitivity)
✅ CE-IVDD marked, recognized by NMPA
✅ Non-invasive

You are encouraged to discuss genetic testing options with your own healthcare service provider. For questions about our Stool DNA Colon Cancer Screening or healthcare service provider network, please feel free to contact us at +852 3604 1305.

#大腸癌 #定期篩檢 #基因檢測 #息肉 #健康生活 #癌症治療 #健康飲食 #健康

06/04/2023

04/04/2023

【清明節及復活節營業時間】
🌟假期將至, Eurofins MGS會作出以下營業安排：

2023年4月5日（三）: 休息
2023年4月6日（四）: 正常營業
2023年4月7日（五）: 休息
2023年4月8日（六）: 休息
2023年4月9日（日）: 休息
2023年4月10日（一）: 休息
2023年4月11日（二）: 正常營業

祝大家假期愉快 ！HAPPY EASTER!

03/04/2023

【Stool DNA Colon Cancer Screening Test by Eurofins MGS】

Colorectal cancer is the 2nd commonest cancer in Hong Kong. Aging, poor diet, genetic factors and other chronic bowel diseases may lead to a higher chance of colorectal cancer.

In January this year, we have launched our Stool DNA Colon Cancer Screening Test.

This test provides a safe, simple and accurate for screening colorectal cancer. With just a small amount of stool sample, this test examines multiple genetic alternations associated with colorectal cancer.

✅ CAP-accredited laboratory
✅ Highly Sensitive (95.3% sensitivity)
✅ CE-IVDD marked, recognized by NMPA
✅ Non-invasive

You are encouraged to discuss genetic testing options with your own healthcare service provider. For questions about our Stool DNA Colon Cancer Screening or healthcare service provider network, please feel free to contact us at +852 3604 1305.

#大腸癌 #定期篩檢 #基因檢測 #息肉 #健康 #癌症

31/03/2023

27/03/2023

Globally, 800 million people are living with obesity. By 2030, the World Health Organisation estimates that 250 million children will be affected by obesity. Ensuring that children have access to nutritious meals as well as promoting a healthy, balanced lifestyle is important to prevent and address childhood obesity.🍎

That’s why the Eurofins Foundation is supporting the Healthy Weight Project led by New Zealand-based organisation Cure Kids. The project aims to scope the creation of a monitoring platform for tracking rates of obesity in young people under 20-years-old across New Zealand, and identify communities in need of greater support to address childhood obesity. 🇳🇿

Learn more:
https://www.eurofins.com/eurofins-foundation/some-supported-projects/better-nutrition/cure-kids-new-zealand/

23/03/2023

Eurofins team spirit😃

21/03/2023

The Eurofins Foundation’s Call for Projects is now open!

Applications for funding are welcome from charities, NGOs, universities, and social businesses whose work is aligned with the Eurofins Foundation's goals:

🌱 Protecting the environment
🍎 Improving human health and nutrition
👩 Promoting diversity and inclusion
🎓 Supporting students and local communities

Nominate a project for support here:
https://www.eurofins.com/eurofins-foundation/submit-a-project/

15/03/2023

歐陸集團公布了2022年財務報告，收入為67.12億歐元。

在經歷了非常強勁的2021年之後，歐陸成功彌補了因2022年COVID-19檢測減少的業績，並加速了其世界級網絡的建設。

2022年，歐陸在收購方面創下紀錄，增加了104,000平方米面積的自有地，以擴大其實驗室網絡。Startup新創投資並無停擺，仍在持續進行。2022年在集團之所有主要營運領域和地區建立了50個新的實驗室。

https://eurofinstw.pse.is/2022FR

Today, Eurofins announces its Full Year Financial Results for 2022, recording €6,712 million in revenues.

After a very strong 2021, Eurofins has fully compensated for the decline in COVID-19 testing in 2022 and accelerated the build-out of its world-class network. 🌎

2022 was a record year for Eurofins in terms of acquisitions, and Eurofins added 104,000m² of surface area to its owned sites to expand its laboratory network. 🥼

Start-up activity has continued, with 50 new start-up laboratories launched in all key areas of activities and regions of the Eurofins Group in 2022. 💡

Read more:
https://www.eurofins.com/media-centre/press-releases/2023-03-01/

07/03/2023

Today, Eurofins announces its Full Year Financial Results for 2022, recording €6,712 million in revenues.

After a very strong 2021, Eurofins has fully compensated for the decline in COVID-19 testing in 2022 and accelerated the build-out of its world-class network. 🌎

2022 was a record year for Eurofins in terms of acquisitions, and Eurofins added 104,000m² of surface area to its owned sites to expand its laboratory network. 🥼

Start-up activity has continued, with 50 new start-up laboratories launched in all key areas of activities and regions of the Eurofins Group in 2022. 💡

Read more:
https://www.eurofins.com/media-centre/press-releases/2023-03-01/

06/02/2023

We’re delighted to announce that the Eurofins Foundation is supporting 93 projects and initiatives in 2022/2023. 🎯

The projects and initiatives receiving donations are aligned with the Eurofins Foundation’s goals to:

👩‍⚕️ Improve health and nutrition
🌱 Protect the environment
👪 Empower local communities
💡 Enable social entrepreneurship
🎓 Support students
🌍 Promote inclusion, diversity and equality
🚨 Provide emergency support